Javascript must be enabled to continue!
Accumulation of CTLA‐4 expressing T lymphocytes in the germinal centres of human lymphoid tissues‘pa
View through CrossRef
CTLA‐4, a coreceptor with sequence homology to CD28 is expressed on T cells after activation. Mice deficient for CTLA‐4 die young from massive infiltration of many organs by activated T cells, which highlights the essential inhibitory role the coreceptor plays in the regulation of the immune response. To study the prevalence and distribution of CTLA‐4 in situ immunohistological analyses were carried out on human tonsils and lymph nodes. Expression of CTLA‐4 was restricted to αβ T cells, and CTLA‐4+ B cells were not observed. In T‐cell areas, 2–10% of T cells were positive for CTLA‐4 with similar percentages in the CD4+ and CD8+ subpopulations. In the germinal centres (GC) the fraction of CTLA‐4+ T cells was much higher (70–90%). This was due to frequent expression of CTLA‐4 on the CD4+ helper subpopulation. GC CD8+ T cells were rare and mostly did not express the coreceptor. The CTLA‐4+ T‐cell fraction was also over‐represented among intraepithelial tonsillar T cells. Cycling (Ki‐67+) and apoptotic (TUNEL+) T cells were never positive for CTLA‐4, while a subset of CD25+ cells did express the coreceptor. Since CTLA‐4 is essential for the physiological limitation of the immune response, GC T cells, which are mostly CTLA‐4 positive, might be important in this process.
Title: Accumulation of CTLA‐4 expressing T lymphocytes in the germinal centres of human lymphoid tissues‘pa
Description:
CTLA‐4, a coreceptor with sequence homology to CD28 is expressed on T cells after activation.
Mice deficient for CTLA‐4 die young from massive infiltration of many organs by activated T cells, which highlights the essential inhibitory role the coreceptor plays in the regulation of the immune response.
To study the prevalence and distribution of CTLA‐4 in situ immunohistological analyses were carried out on human tonsils and lymph nodes.
Expression of CTLA‐4 was restricted to αβ T cells, and CTLA‐4+ B cells were not observed.
In T‐cell areas, 2–10% of T cells were positive for CTLA‐4 with similar percentages in the CD4+ and CD8+ subpopulations.
In the germinal centres (GC) the fraction of CTLA‐4+ T cells was much higher (70–90%).
This was due to frequent expression of CTLA‐4 on the CD4+ helper subpopulation.
GC CD8+ T cells were rare and mostly did not express the coreceptor.
The CTLA‐4+ T‐cell fraction was also over‐represented among intraepithelial tonsillar T cells.
Cycling (Ki‐67+) and apoptotic (TUNEL+) T cells were never positive for CTLA‐4, while a subset of CD25+ cells did express the coreceptor.
Since CTLA‐4 is essential for the physiological limitation of the immune response, GC T cells, which are mostly CTLA‐4 positive, might be important in this process.
Related Results
Abstract 1627: Preclinical characterization of a novel CTLA-4-targeted ETB for direct Treg depletion
Abstract 1627: Preclinical characterization of a novel CTLA-4-targeted ETB for direct Treg depletion
Abstract
Regulatory T cell (Treg) depletion enhances the anti-tumor efficacy of CTLA-4 targeted mAbs in preclinical models, and is a mechanism supported by retrospec...
Abstract 1350: KD6001: A promising new anti-CTLA-4 human monoclonal antibody for cancer therapy
Abstract 1350: KD6001: A promising new anti-CTLA-4 human monoclonal antibody for cancer therapy
Abstract
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a crucial immune checkpoint that negatively regulates T cell activation. Inhibiting this negative regulation th...
CTLA-4 blockade reverses the Foxp3+ T-regulatory-cell suppression of anti-tuberculosis T-cell effector responses
CTLA-4 blockade reverses the Foxp3+ T-regulatory-cell suppression of anti-tuberculosis T-cell effector responses
AbstractBackgroundsIt has been well described that Foxp3+ T regulatory (Treg) cells suppress immune responses and that murine cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) c...
Early Mixed Lymphoid Chimerism in Acute Myeloid Leukemia Patients Undergoing Allogeneic Transplantation after a Myeloablative Busulfan-Based Conditioning Regimen
Early Mixed Lymphoid Chimerism in Acute Myeloid Leukemia Patients Undergoing Allogeneic Transplantation after a Myeloablative Busulfan-Based Conditioning Regimen
Introduction
The combination of fludarabine with a myeloablative dose of busulfan has proven to lower post-transplant non-relapse mortality (NRM) with regards to ...
A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
Abstract
Background
Cytokine-based drugs are currently being explored as alternative cancer immunotherapies. While the cytokine ...
Germinal Centres
Germinal Centres
AbstractGerminal centres are transient lymphoid structures appearing inside lymph follicles after an antigenic stimulation. They are closely associated with T‐dependent zones and o...
Subpopulations of B- And T-Lymphocytes and NK (Natural Killer) Cells (LGL – Large Granular Lymlphocytes) in Patients With Infectious Mononucleosis
Subpopulations of B- And T-Lymphocytes and NK (Natural Killer) Cells (LGL – Large Granular Lymlphocytes) in Patients With Infectious Mononucleosis
In a group of 54 patients with verified diagnoses of infectious mononucleosis values of leukocytes, lymphocytes and atypical mononuclear cells (AMNC) in the peripheral blood were m...
Abstract 6065: Preclinical evaluation of LM-168: A next-generation anti-CTLA4 antibody with promising efficacy and reduced toxicity
Abstract 6065: Preclinical evaluation of LM-168: A next-generation anti-CTLA4 antibody with promising efficacy and reduced toxicity
Abstract
Background:
Anti-CTLA-4 antibodies have demonstrated encouraging clinical outcomes across various tumor types, but syst...

